Annual Operating Expenses
$17.13 M
+$237.00 K+1.40%
December 31, 2023
Summary
- As of February 12, 2025, ALLR annual total operating expenses is $17.13 million, with the most recent change of +$237.00 thousand (+1.40%) on December 31, 2023.
- During the last 3 years, ALLR annual operating expenses has risen by +$8.81 million (+105.90%).
- ALLR annual operating expenses is now -35.50% below its all-time high of $26.56 million, reached on December 31, 2021.
Performance
ALLR Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Expenses
$2.61 M
-$761.00 K-22.57%
September 1, 2024
Summary
- As of February 12, 2025, ALLR quarterly total operating expenses is $2.61 million, with the most recent change of -$761.00 thousand (-22.57%) on September 1, 2024.
- Over the past year, ALLR quarterly operating expenses has dropped by -$1.63 million (-38.44%).
- ALLR quarterly operating expenses is now -83.42% below its all-time high of $15.74 million, reached on December 31, 2021.
Performance
ALLR Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Expenses Formula
Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses
ALLR Operating Expenses Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +1.4% | -38.4% |
3 y3 years | +105.9% | -38.4% |
5 y5 years | +67.3% | -38.4% |
ALLR Operating Expenses Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -35.5% | +1.4% | -83.4% | at low |
5 y | 5-year | -35.5% | +105.9% | -83.4% | +50.2% |
alltime | all time | -35.5% | +105.9% | -83.4% | +50.2% |
Allarity Therapeutics Operating Expenses History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $2.61 M(-22.6%) |
Jun 2024 | - | $3.37 M(-20.5%) |
Mar 2024 | - | $4.24 M(-13.1%) |
Dec 2023 | $17.13 M(+1.4%) | $4.88 M(+10.2%) |
Sep 2023 | - | $4.43 M(+6.5%) |
Jun 2023 | - | $4.16 M(+13.3%) |
Mar 2023 | - | $3.67 M(+15.1%) |
Dec 2022 | $16.89 M | $3.19 M(-30.2%) |
Sep 2022 | - | $4.56 M(-5.8%) |
Date | Annual | Quarterly |
---|---|---|
Jun 2022 | - | $4.84 M(+12.6%) |
Mar 2022 | - | $4.30 M(-72.7%) |
Dec 2021 | $26.56 M(+219.2%) | $15.74 M(+296.1%) |
Sep 2021 | - | $3.97 M(-9.2%) |
Jun 2021 | - | $4.38 M(+77.7%) |
Mar 2021 | - | $2.46 M(-2.4%) |
Dec 2020 | $8.32 M(-18.7%) | $2.52 M(+45.1%) |
Sep 2020 | - | $1.74 M |
Dec 2019 | $10.24 M | - |
FAQ
- What is Allarity Therapeutics annual total operating expenses?
- What is the all time high annual operating expenses for Allarity Therapeutics?
- What is Allarity Therapeutics annual operating expenses year-on-year change?
- What is Allarity Therapeutics quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Allarity Therapeutics?
- What is Allarity Therapeutics quarterly operating expenses year-on-year change?
What is Allarity Therapeutics annual total operating expenses?
The current annual operating expenses of ALLR is $17.13 M
What is the all time high annual operating expenses for Allarity Therapeutics?
Allarity Therapeutics all-time high annual total operating expenses is $26.56 M
What is Allarity Therapeutics annual operating expenses year-on-year change?
Over the past year, ALLR annual total operating expenses has changed by +$237.00 K (+1.40%)
What is Allarity Therapeutics quarterly total operating expenses?
The current quarterly operating expenses of ALLR is $2.61 M
What is the all time high quarterly operating expenses for Allarity Therapeutics?
Allarity Therapeutics all-time high quarterly total operating expenses is $15.74 M
What is Allarity Therapeutics quarterly operating expenses year-on-year change?
Over the past year, ALLR quarterly total operating expenses has changed by -$1.63 M (-38.44%)